Jacqueline Corrigan-Curay, retiring acting CDER director
June 23, 2025 10:20 AM EDTUpdated 01:12 PM
People
FDA+

Act­ing CDER chief is leav­ing af­ter al­most nine years at FDA

Zachary Brennan

Senior Editor

The top drug reg­u­la­tor at the FDA is re­tir­ing, ac­cord­ing to an email re­viewed by End­points News and con­firmed by sev­er­al in­di­vid­u­als with­in the agency …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­vo ends short-lived part­ner­ship with Hims over com­pound­ed obe­si­ty drugs

Up­dat­ed: A puz­zling up­date from No­vo Nordisk and new da­ta from Roche at #ADA25

Lil­ly’s bima­grum­ab boosts weight and fat loss when added to Novo's We­govy

Ex­elix­is' pos­i­tive Phase 3 col­orec­tal can­cer da­ta boost stock

Up­dat­ed: Com­pass claims Phase 3 win in de­pres­sion for psilo­cy­bin drug, yet stock plum­mets

sponsored

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

A service from the Financial Times